newsfilter
← Latest News
Business Wire·

Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive Officer

– Severino joins Sarepta’s Board of Directors – Doug Ingram to retire from Sarepta Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the